RxDoctor Payments Data

John Michels, MD

Interventional Pain Medicine · Dallas, TXNPI 1912137910

Payments from drug & device makers

$20,073in general payments, 2019–2025

Across 305 payments — averaging $65.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$10K
  • Acelrx Pharmaceuticals, Inc.$4K
  • Nevro Corp.$1K
  • Medtronic$693
  • Pylant Medical$669
  • MML US, Inc.$560
  • plus $3K from 25 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Consulting fees$4,41322%
  • Speaking & faculty fees$3,50017%
  • Travel & lodging$3,05915%
  • Food & beverage$9,03545%
  • Gifts$140%
  • Entertainment$520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,073 in reported general payments places this provider in the 75th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$463,735
Medicare patients
605
Services billed
2,978

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$1,196
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$456
Gabapentin37$431
Oxycodone Hcl13$244
Tramadol Hcl34$204
Pregabalin11$68

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →